A Novel De Novo Missense Mutation in KIF1A Associated with Young-Onset Upper-Limb Amyotrophic Lateral Sclerosis.
Emilien BernardFlorent CluseAdrien BohicMarc HermierCédric RaoulPascal LeblancClaire GuissartPublished in: International journal of molecular sciences (2024)
We investigate the etiology of amyotrophic lateral sclerosis (ALS) in a 35-year-old woman presenting with progressive weakness in her left upper limb. Prior to sequencing, a comprehensive neurological work-up was performed, including neurological examination, electrophysiology, biomarker assessment, and brain and spinal cord MRI. Six months before evaluation, the patient experienced weakness and atrophy in her left hand, accompanied by brisk reflexes and Hoffman sign in the same arm. Electroneuromyography revealed lower motor neuron involvement in three body regions. Neurofilament light chains were elevated in her cerebrospinal fluid. Brain imaging showed asymmetrical T2 hyperintensity of the corticospinal tracts and T2 linear hypointensity of the precentral gyri. Trio genome sequencing identified a likely pathogenic de novo variant in the KIF1A gene (NM_001244008.2): c.574A>G, p.(Ile192Val). Pathogenic variants in KIF1A have been associated with a wide range of neurological manifestations called KIF1A-associated neurological diseases (KAND). This report describes a likely pathogenic de novo variant in KIF1A associated with ALS, expanding the phenotypic spectrum of KAND and our understanding of the pathophysiology of ALS.
Keyphrases
- amyotrophic lateral sclerosis
- upper limb
- cerebrospinal fluid
- cerebral ischemia
- spinal cord
- single cell
- resting state
- copy number
- case report
- white matter
- genome wide
- high resolution
- magnetic resonance imaging
- subarachnoid hemorrhage
- photodynamic therapy
- functional connectivity
- contrast enhanced
- blood brain barrier
- magnetic resonance
- computed tomography
- brain injury
- dna methylation
- mass spectrometry
- gene expression
- neuropathic pain